Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kerberos Proximal Solutions Inc.

This article was originally published in Start Up

Executive Summary

Kerberos' KEPTembolic protection catheter system uses an alternating rinsing and aspiration action -- "Rinspiration" -- to capture and retrieve more embolic mass, including small particles.

You may also be interested in...



FoxHollow Makes First Acquisition, Buys Kerberos

After much anticipation, atherectomy leader FoxHollow Technologies has finally joined the ranks of the acquirers, buying Kerberos Proximal Solutions, maker of the Rinspiration system, which is a catheter-based system that both rinses and aspirates vessels to remove blood clots and soft emboli. Both companies are currently focusing on treating peripheral vascular disease.

FoxHollow Makes First Acquisition, Buys Kerberos

After much anticipation, atherectomy leader FoxHollow Technologies has finally joined the ranks of the acquirers, buying Kerberos Proximal Solutions, maker of the Rinspiration system, which is a catheter-based system that both rinses and aspirates vessels to remove blood clots and soft emboli. Both companies are currently focusing on treating peripheral vascular disease.

Embolic Protection: Better Outcomes Not Enough

For 20 years, interventional cardiologists denied the need for embolic protection devices, considering embolic events to generally be the infrequent results of poor technique. Nevertheless, recent data has revealed embolization as a potentially serious and relatively common event during percutaneous coronary interventions. While embolic protection devices have been shown to dramatically reduce embolic complications, physician adoption is slow. Several companies are developing different approaches to protect against embolization, recognizing that better patient data alone isn't enough to convince interventionalists to employ these devices.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT037189

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel